The utility of diuretic therapy in preventing heart failure is now well accepted and it is possible in this trial that doxazosin was not a drug that caused heart failure but rather one that simply ...

Ovarian cancer is the deadliest gynecologic malignancy globally and is increasing in incidence and mortality with currently ...

Beta-blockers are widely used medications that help manage high blood pressure by reducing the heart rate and relaxing blood ...

In "remarkable" work, a patch of engineered heart muscle cells was used to strengthen a patient's heart before transplant.

The study offers promising news for people with type 2 diabetes. By using SGLT2 inhibitors, they may be able to lower their ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...

Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an enzyme, alpha-kinase 2 (ALPK2) that is specifically ...

A specially designed drug prevented laboratory mice from developing heart failure after heart attacks, according to new research from Cedars-Sinai. This discovery could lead to new treatments to ...

Cytokinetics' hopes of resurrecting cardiac myosin activator omecamtiv mecarbil have suffered another setback, after the drug failed to show a benefit in a phase 3 heart failure study. In the ...

Congestive heart failure is a disease state distinguished by the regular presence of both renal and hepatic abnormalities in drug handling. One such abnormality involves flaws in the process of ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

And despite its newness to gynecologic oncology, it is a familiar pharmaceutical that has been in use as an approved drug since the mid-1990s for acute heart failure. Cancer biologists hope to ...